Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Ceritinib Market Growth 2022-2028

  • LP 4768491
  • 77 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Ceritinib will have significant change from previous year. According to our (LP Information) latest study, the global Ceritinib market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Ceritinib market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Ceritinib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ceritinib market, reaching US$ million by the year 2028. As for the Europe Ceritinib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Ceritinib players cover Novartis, Natco, Lucius Pharmaceuticals, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Ceritinib market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

50 Capsules/Box

90 Capsules/Box

150 Capsules/Box

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Clinic

Pharmacy

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Novartis

Natco

Lucius Pharmaceuticals

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Ceritinib Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Ceritinib by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Ceritinib by Country/Region, 2017, 2022 & 2028

2.2 Ceritinib Segment by Type

2.2.1 50 Capsules/Box

2.2.2 90 Capsules/Box

2.2.3 150 Capsules/Box

2.3 Ceritinib Sales by Type

2.3.1 Global Ceritinib Sales Market Share by Type (2017-2022)

2.3.2 Global Ceritinib Revenue and Market Share by Type (2017-2022)

2.3.3 Global Ceritinib Sale Price by Type (2017-2022)

2.4 Ceritinib Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Pharmacy

2.4.4 Other

2.5 Ceritinib Sales by Application

2.5.1 Global Ceritinib Sale Market Share by Application (2017-2022)

2.5.2 Global Ceritinib Revenue and Market Share by Application (2017-2022)

2.5.3 Global Ceritinib Sale Price by Application (2017-2022)

3 Global Ceritinib by Company

3.1 Global Ceritinib Breakdown Data by Company

3.1.1 Global Ceritinib Annual Sales by Company (2020-2022)

3.1.2 Global Ceritinib Sales Market Share by Company (2020-2022)

3.2 Global Ceritinib Annual Revenue by Company (2020-2022)

3.2.1 Global Ceritinib Revenue by Company (2020-2022)

3.2.2 Global Ceritinib Revenue Market Share by Company (2020-2022)

3.3 Global Ceritinib Sale Price by Company

3.4 Key Manufacturers Ceritinib Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Ceritinib Product Location Distribution

3.4.2 Players Ceritinib Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Ceritinib by Geographic Region

4.1 World Historic Ceritinib Market Size by Geographic Region (2017-2022)

4.1.1 Global Ceritinib Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Ceritinib Annual Revenue by Geographic Region

4.2 World Historic Ceritinib Market Size by Country/Region (2017-2022)

4.2.1 Global Ceritinib Annual Sales by Country/Region (2017-2022)

4.2.2 Global Ceritinib Annual Revenue by Country/Region

4.3 Americas Ceritinib Sales Growth

4.4 APAC Ceritinib Sales Growth

4.5 Europe Ceritinib Sales Growth

4.6 Middle East & Africa Ceritinib Sales Growth

5 Americas

5.1 Americas Ceritinib Sales by Country

5.1.1 Americas Ceritinib Sales by Country (2017-2022)

5.1.2 Americas Ceritinib Revenue by Country (2017-2022)

5.2 Americas Ceritinib Sales by Type

5.3 Americas Ceritinib Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Ceritinib Sales by Region

6.1.1 APAC Ceritinib Sales by Region (2017-2022)

6.1.2 APAC Ceritinib Revenue by Region (2017-2022)

6.2 APAC Ceritinib Sales by Type

6.3 APAC Ceritinib Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Ceritinib by Country

7.1.1 Europe Ceritinib Sales by Country (2017-2022)

7.1.2 Europe Ceritinib Revenue by Country (2017-2022)

7.2 Europe Ceritinib Sales by Type

7.3 Europe Ceritinib Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Ceritinib by Country

8.1.1 Middle East & Africa Ceritinib Sales by Country (2017-2022)

8.1.2 Middle East & Africa Ceritinib Revenue by Country (2017-2022)

8.2 Middle East & Africa Ceritinib Sales by Type

8.3 Middle East & Africa Ceritinib Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Ceritinib

10.3 Manufacturing Process Analysis of Ceritinib

10.4 Industry Chain Structure of Ceritinib

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Ceritinib Distributors

11.3 Ceritinib Customer

12 World Forecast Review for Ceritinib by Geographic Region

12.1 Global Ceritinib Market Size Forecast by Region

12.1.1 Global Ceritinib Forecast by Region (2023-2028)

12.1.2 Global Ceritinib Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Ceritinib Forecast by Type

12.7 Global Ceritinib Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Ceritinib Product Offered

13.1.3 Novartis Ceritinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

13.2 Natco

13.2.1 Natco Company Information

13.2.2 Natco Ceritinib Product Offered

13.2.3 Natco Ceritinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Natco Main Business Overview

13.2.5 Natco Latest Developments

13.3 Lucius Pharmaceuticals

13.3.1 Lucius Pharmaceuticals Company Information

13.3.2 Lucius Pharmaceuticals Ceritinib Product Offered

13.3.3 Lucius Pharmaceuticals Ceritinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Lucius Pharmaceuticals Main Business Overview

13.3.5 Lucius Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Ceritinib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Ceritinib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 50 Capsules/Box

Table 4. Major Players of 90 Capsules/Box

Table 5. Major Players of 150 Capsules/Box

Table 6. Global Ceritinib Sales by Type (2017-2022) & (K Pcs)

Table 7. Global Ceritinib Sales Market Share by Type (2017-2022)

Table 8. Global Ceritinib Revenue by Type (2017-2022) & ($ million)

Table 9. Global Ceritinib Revenue Market Share by Type (2017-2022)

Table 10. Global Ceritinib Sale Price by Type (2017-2022) & (USD/Pcs)

Table 11. Global Ceritinib Sales by Application (2017-2022) & (K Pcs)

Table 12. Global Ceritinib Sales Market Share by Application (2017-2022)

Table 13. Global Ceritinib Revenue by Application (2017-2022)

Table 14. Global Ceritinib Revenue Market Share by Application (2017-2022)

Table 15. Global Ceritinib Sale Price by Application (2017-2022) & (USD/Pcs)

Table 16. Global Ceritinib Sales by Company (2020-2022) & (K Pcs)

Table 17. Global Ceritinib Sales Market Share by Company (2020-2022)

Table 18. Global Ceritinib Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Ceritinib Revenue Market Share by Company (2020-2022)

Table 20. Global Ceritinib Sale Price by Company (2020-2022) & (USD/Pcs)

Table 21. Key Manufacturers Ceritinib Producing Area Distribution and Sales Area

Table 22. Players Ceritinib Products Offered

Table 23. Ceritinib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Ceritinib Sales by Geographic Region (2017-2022) & (K Pcs)

Table 27. Global Ceritinib Sales Market Share Geographic Region (2017-2022)

Table 28. Global Ceritinib Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Ceritinib Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Ceritinib Sales by Country/Region (2017-2022) & (K Pcs)

Table 31. Global Ceritinib Sales Market Share by Country/Region (2017-2022)

Table 32. Global Ceritinib Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Ceritinib Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Ceritinib Sales by Country (2017-2022) & (K Pcs)

Table 35. Americas Ceritinib Sales Market Share by Country (2017-2022)

Table 36. Americas Ceritinib Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Ceritinib Revenue Market Share by Country (2017-2022)

Table 38. Americas Ceritinib Sales by Type (2017-2022) & (K Pcs)

Table 39. Americas Ceritinib Sales Market Share by Type (2017-2022)

Table 40. Americas Ceritinib Sales by Application (2017-2022) & (K Pcs)

Table 41. Americas Ceritinib Sales Market Share by Application (2017-2022)

Table 42. APAC Ceritinib Sales by Region (2017-2022) & (K Pcs)

Table 43. APAC Ceritinib Sales Market Share by Region (2017-2022)

Table 44. APAC Ceritinib Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Ceritinib Revenue Market Share by Region (2017-2022)

Table 46. APAC Ceritinib Sales by Type (2017-2022) & (K Pcs)

Table 47. APAC Ceritinib Sales Market Share by Type (2017-2022)

Table 48. APAC Ceritinib Sales by Application (2017-2022) & (K Pcs)

Table 49. APAC Ceritinib Sales Market Share by Application (2017-2022)

Table 50. Europe Ceritinib Sales by Country (2017-2022) & (K Pcs)

Table 51. Europe Ceritinib Sales Market Share by Country (2017-2022)

Table 52. Europe Ceritinib Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Ceritinib Revenue Market Share by Country (2017-2022)

Table 54. Europe Ceritinib Sales by Type (2017-2022) & (K Pcs)

Table 55. Europe Ceritinib Sales Market Share by Type (2017-2022)

Table 56. Europe Ceritinib Sales by Application (2017-2022) & (K Pcs)

Table 57. Europe Ceritinib Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Ceritinib Sales by Country (2017-2022) & (K Pcs)

Table 59. Middle East & Africa Ceritinib Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Ceritinib Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Ceritinib Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Ceritinib Sales by Type (2017-2022) & (K Pcs)

Table 63. Middle East & Africa Ceritinib Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Ceritinib Sales by Application (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Ceritinib Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Ceritinib

Table 67. Key Market Challenges & Risks of Ceritinib

Table 68. Key Industry Trends of Ceritinib

Table 69. Ceritinib Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Ceritinib Distributors List

Table 72. Ceritinib Customer List

Table 73. Global Ceritinib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 74. Global Ceritinib Sales Market Forecast by Region

Table 75. Global Ceritinib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Ceritinib Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Ceritinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 78. Americas Ceritinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Ceritinib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 80. APAC Ceritinib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Ceritinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Europe Ceritinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Ceritinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Middle East & Africa Ceritinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Ceritinib Sales Forecast by Type (2023-2028) & (K Pcs)

Table 86. Global Ceritinib Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Ceritinib Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Ceritinib Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Ceritinib Sales Forecast by Application (2023-2028) & (K Pcs)

Table 90. Global Ceritinib Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Ceritinib Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Ceritinib Revenue Market Share Forecast by Application (2023-2028)

Table 93. Novartis Basic Information, Ceritinib Manufacturing Base, Sales Area and Its Competitors

Table 94. Novartis Ceritinib Product Offered

Table 95. Novartis Ceritinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 96. Novartis Main Business

Table 97. Novartis Latest Developments

Table 98. Natco Basic Information, Ceritinib Manufacturing Base, Sales Area and Its Competitors

Table 99. Natco Ceritinib Product Offered

Table 100. Natco Ceritinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. Natco Main Business

Table 102. Natco Latest Developments

Table 103. Lucius Pharmaceuticals Basic Information, Ceritinib Manufacturing Base, Sales Area and Its Competitors

Table 104. Lucius Pharmaceuticals Ceritinib Product Offered

Table 105. Lucius Pharmaceuticals Ceritinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 106. Lucius Pharmaceuticals Main Business

Table 107. Lucius Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Ceritinib

Figure 2. Ceritinib Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Ceritinib Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Ceritinib Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Ceritinib Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 50 Capsules/Box

Figure 10. Product Picture of 90 Capsules/Box

Figure 11. Product Picture of 150 Capsules/Box

Figure 12. Global Ceritinib Sales Market Share by Type in 2021

Figure 13. Global Ceritinib Revenue Market Share by Type (2017-2022)

Figure 14. Ceritinib Consumed in Hospital

Figure 15. Global Ceritinib Market: Hospital (2017-2022) & (K Pcs)

Figure 16. Ceritinib Consumed in Clinic

Figure 17. Global Ceritinib Market: Clinic (2017-2022) & (K Pcs)

Figure 18. Ceritinib Consumed in Pharmacy

Figure 19. Global Ceritinib Market: Pharmacy (2017-2022) & (K Pcs)

Figure 20. Ceritinib Consumed in Other

Figure 21. Global Ceritinib Market: Other (2017-2022) & (K Pcs)

Figure 22. Global Ceritinib Sales Market Share by Application (2017-2022)

Figure 23. Global Ceritinib Revenue Market Share by Application in 2021

Figure 24. Ceritinib Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Ceritinib Revenue Market Share by Company in 2021

Figure 26. Global Ceritinib Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Ceritinib Revenue Market Share by Geographic Region in 2021

Figure 28. Global Ceritinib Sales Market Share by Region (2017-2022)

Figure 29. Global Ceritinib Revenue Market Share by Country/Region in 2021

Figure 30. Americas Ceritinib Sales 2017-2022 (K Pcs)

Figure 31. Americas Ceritinib Revenue 2017-2022 ($ Millions)

Figure 32. APAC Ceritinib Sales 2017-2022 (K Pcs)

Figure 33. APAC Ceritinib Revenue 2017-2022 ($ Millions)

Figure 34. Europe Ceritinib Sales 2017-2022 (K Pcs)

Figure 35. Europe Ceritinib Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Ceritinib Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Ceritinib Revenue 2017-2022 ($ Millions)

Figure 38. Americas Ceritinib Sales Market Share by Country in 2021

Figure 39. Americas Ceritinib Revenue Market Share by Country in 2021

Figure 40. United States Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Ceritinib Sales Market Share by Region in 2021

Figure 45. APAC Ceritinib Revenue Market Share by Regions in 2021

Figure 46. China Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Ceritinib Sales Market Share by Country in 2021

Figure 53. Europe Ceritinib Revenue Market Share by Country in 2021

Figure 54. Germany Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Ceritinib Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Ceritinib Revenue Market Share by Country in 2021

Figure 61. Egypt Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Ceritinib Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Ceritinib in 2021

Figure 67. Manufacturing Process Analysis of Ceritinib

Figure 68. Industry Chain Structure of Ceritinib

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390